Success Metrics

Clinical Success Rate
78.3%

Based on 18 completed trials

Completion Rate
78%(18/23)
Active Trials
1(3%)
Results Posted
28%(5 trials)
Terminated
5(16%)

Phase Distribution

Ph phase_2
5
16%
Ph phase_1
6
19%
Ph not_applicable
8
25%
Ph phase_3
7
22%
Ph early_phase_1
2
6%
Ph phase_4
3
9%

Phase Distribution

8

Early Stage

5

Mid Stage

10

Late Stage

Phase Distribution31 total trials
Early Phase 1First-in-human
2(6.5%)
Phase 1Safety & dosage
6(19.4%)
Phase 2Efficacy & side effects
5(16.1%)
Phase 3Large-scale testing
7(22.6%)
Phase 4Post-market surveillance
3(9.7%)
N/ANon-phased studies
8(25.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.0%

18 of 25 finished

Non-Completion Rate

28.0%

7 ended early

Currently Active

1

trials recruiting

Total Trials

32

all time

Status Distribution
Active(2)
Completed(18)
Terminated(7)
Other(5)

Detailed Status

Completed18
Terminated5
unknown5
Withdrawn2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
1
Success Rate
78.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (6.5%)
Phase 16 (19.4%)
Phase 25 (16.1%)
Phase 37 (22.6%)
Phase 43 (9.7%)
N/A8 (25.8%)

Trials by Status

completed1856%
terminated516%
unknown516%
not_yet_recruiting13%
recruiting13%
withdrawn26%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT05935761Phase 2

Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial

Not Yet Recruiting
NCT03228732Early Phase 1

The Effects of Fluoxetine and/or DHEA

Recruiting
NCT05316272Not Applicable

Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women

Completed
NCT03227458Not Applicable

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

Completed
NCT05471453Not Applicable

Effectiveness of Adjuvant Supplements Prior to in IVF

Completed
NCT03491007Phase 2

Neurosteroids in PTSD - Biomarkers to Therapeutics

Terminated
NCT01662466Phase 1

Effect of Testosterone Treatment on Embryo Quality

Unknown
NCT02866253Phase 4

Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles

Completed
NCT00972023Phase 1

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Terminated
NCT02683148Phase 1

DHEA in Synovial Sarcoma Patients

Terminated
NCT02268032Phase 1

Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve

Completed
NCT02766764Phase 4

Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI

Unknown
NCT01256671Phase 3

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

Completed
NCT01256684Phase 3

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

Completed
NCT01358760Phase 3

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

Completed
NCT02549690Not Applicable

Testosterone Gel in Poor Responders Undergoing IVF

Withdrawn
NCT00429806Phase 1

DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy

Completed
NCT02000375Phase 2

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)

Terminated
NCT02736591Phase 3

Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response

Unknown
NCT02561793Phase 3

DHEA Versus Placebo in Women With Poor Ovarian Response

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
32